Patient with adrenal insufficiency due to a de novo mutation in the NR0B1 gene
Author:
Bravo Nieto Daniel1, García Fernández Alba S.1, Díaz Troyano Noelia1, Arnaiz Marina Giralt1, Arias García Andrea1, Fernández Álvarez Paula1, Campos Martorell Ariadna2, Ferrer Costa Roser1, Clemente León María2
Affiliation:
1. Servicio de Bioquímica, Laboratorios Clínicos , Hospital Universitari Vall d’Hebron , Barcelona , Spain 2. Unidad de endocrinología pediátrica, Hospital Universitari Vall d’Hebron , Barcelona , Spain
Abstract
Abstract
Objectives
Congenital X-linked adrenal hypoplasia is a rare disease with a known genetic basis characterized by adrenal insufficiency, hypogonadotropic hypogonadism, and a wide variety of clinical manifestations.
Case presentation
We present the case of a 26-day old male newborn with symptoms consistent with adrenal insufficiency, hyponatremia, and hyperkalemia. Following NaCl and fludrocortisone supplementation, the patient remained clinically stable. 17-OH-progesterone testing excluded congenital adrenal hyperplasia. The rest of hormones were within normal limits, except for adrenocorticotropic hormone (ACTH), which was significantly elevated, and aldosterone, which was below the reference value. Further testing included very long chain fatty acids to exclude adrenoleukodystrophy, the CYP11B2 gene (aldosterone synthase), and an MRI to screen for other morphological abnormalities. All tests yielded normal results. Finally, after cortisol deficiency was detected, expanded genetic testing revealed a mutation in the NR0B1 gene, which led to a diagnosis of congenital adrenal hypoplasia.
Conclusions
Diagnosis of congenital adrenal hypoplasia is challenging due to the heterogeneity of both clinical manifestations and laboratory abnormalities. As a result, diagnosis requires close monitoring and genetic testing.
Publisher
Walter de Gruyter GmbH
Subject
Medical Laboratory Technology,Education,Medicine (miscellaneous)
Reference13 articles.
1. Achermann, JC, Vilain, EJ. NR0B1-Related adrenal hypoplasia congenita. 2001 (updated 2018). In: Adam, MP, Everman, DB, Mirzaa, GM, Pagon, RA, Wallace, SE, Bean, LJH, et al.. editors. GeneReviews®: University of Washington, Seattle:1993–2022 pp. 2. Muscatelli, F, Strom, TM, Walker, AP, Zanaria, E, Récan, D, Meindl, A, et al.. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672–6. https://doi.org/10.1038/372672a0. 3. Connell, JMC, Fraser, R, MacKenzie, SM, Friel, EC, Ingram, MC, Holloway, CD, et al.. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol 2004;207:243–7. https://doi.org/10.1016/j.mce.2003.10.025. 4. Stowasser, M, Gordon, RD. Familial hyperaldosteronism. J Steroid Biochem Mol Bio 2001;78:215–29. https://doi.org/10.1016/s0960-0760(01)00097-8. 5. Home – SNP – NCBI. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/snp/ [Accessed 19 abr 2022].
|
|